Compare ALVO & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | ULCC |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 2017 |
| Metric | ALVO | ULCC |
|---|---|---|
| Price | $5.85 | $6.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 8 |
| Target Price | ★ $8.00 | $5.21 |
| AVG Volume (30 Days) | 972.6K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,724,000,000.00 |
| Revenue This Year | $13.28 | $23.76 |
| Revenue Next Year | $18.63 | $11.48 |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.94 | $3.02 |
| 52 Week High | $9.05 | $8.41 |
| Indicator | ALVO | ULCC |
|---|---|---|
| Relative Strength Index (RSI) | 72.69 | 53.55 |
| Support Level | $3.10 | $5.39 |
| Resistance Level | N/A | $6.23 |
| Average True Range (ATR) | 0.26 | 0.25 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 81.47 | 71.21 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos, and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. The majority of revenue is from Domestic flight follow by International.